CS235196B1 - Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline - Google Patents

Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline Download PDF

Info

Publication number
CS235196B1
CS235196B1 CS841307A CS130784A CS235196B1 CS 235196 B1 CS235196 B1 CS 235196B1 CS 841307 A CS841307 A CS 841307A CS 130784 A CS130784 A CS 130784A CS 235196 B1 CS235196 B1 CS 235196B1
Authority
CS
Czechoslovakia
Prior art keywords
dihydro
oxo
quinoline
pyrazolo
preparation
Prior art date
Application number
CS841307A
Other languages
Czech (cs)
Inventor
Viktor Zikan
Stanislav Radl
Original Assignee
Viktor Zikan
Stanislav Radl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS838460A external-priority patent/CS235183B1/en
Application filed by Viktor Zikan, Stanislav Radl filed Critical Viktor Zikan
Priority to CS841307A priority Critical patent/CS235196B1/en
Publication of CS235196B1 publication Critical patent/CS235196B1/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Vynález se týká nového způsobu přípravy 4,9-dihydro-3,9-dimethyl-4-oxo-lH-pyrazolo- (3,4-bjohinolinu, vyznačujícího se tím, že se zahřívá 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H- -pyrazolo[ 3,4-b ] chinolin s hydrochloridem pyridinu na teplotu 200 až 240 °C, výhodně na teplotu 220 °C.The invention relates to a new process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo-(3,4-b)quinoline, characterized in that 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo[3,4-b]quinoline is heated with pyridine hydrochloride to a temperature of 200 to 240 °C, preferably to a temperature of 220 °C.

Description

Vynález se týká nového způsobu přípravyThe invention relates to a novel preparation process

4,9-dihydro-3,9-dimethyl-4-oxo-lH-pyrazolo[3,4-b]chinolinu vzorce I4,9-Dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo [3,4-b] quinoline of Formula I

Uvedená sloučenina vzorce I slouží jako meziprodukt pro přípravu biologicky významných látek, zejména s protivirovým účinkem.Said compound of formula (I) serves as an intermediate for the preparation of biologically important substances, in particular having antiviral activity.

Uvedená sloučenina vzorce I je známá látka, je popsána její příprava, vyznačující se tím, že se zahřívá 4-(2-fluorfenyl-6,3-dihydro-l,3,8-trimethylpyrazolo (3,4-e )(1,4) diazepin-7(lH)on s hydrochloridem pyridinu na teplotu 210 až 215 °C [DeWald H. A.; J. Heterocyclic Chem. 11, 1061 (1974)].Said compound of formula (I) is a known substance, the preparation of which is characterized by heating 4- (2-fluorophenyl-6,3-dihydro-1,3,8-trimethylpyrazolo (3,4-e) (1, 2-fluorophenyl)). 4) diazepin-7 (1H) on with pyridine hydrochloride at 210-215 ° C [DeWald HA; J. Heterocyclic Chem. 11, 1061 (1974)].

Uvedená sloučenina vzorce I byla připravena způsobem podle vynálezu, vyznačující se tím, že se zahřívá 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo (3,4-b) chinolin (čs. autorské osvědčení č. 235 168 s hydrochloridem pyridinu při teplotě 200 až 240 °C, výhodně při teplotě 220 °C.Said compound of formula (I) was prepared by the process of the invention, characterized by heating 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo (3,4-b) quinoline (U.S. Pat. No. 235 168 with pyridine hydrochloride at a temperature of 200 to 240 ° C, preferably at a temperature of 220 ° C.

Vzhledem ke snadné připravitelnosti výchozího 4,9-dlhydro-2,3,9-trimethyl-4-oxo-2H-pyrazolof 3,4-b) chinolinu (čs. autorské osvědčení čís. 235168), a vzhledem k obtížné přípravě 4- (2-fluorfenyl)6,8-dihydro-l,3,8-trimethylpyrazolo[ 3,4-e] ((l,4]diazepin-7(lH)onu, je zřejmá výhodnost přípravy sloučeniny vzorce I podle vynálezu.Given the ease of preparation of the starting 4,9-dlhydro-2,3,9-trimethyl-4-oxo-2H-pyrazolof 3,4-b) quinoline (cf. No. 235168), and the difficult preparation of 4- (2-fluorophenyl) 6,8-dihydro-1,3,8-trimethylpyrazolo [3,4-e] ((1,4) diazepin-7 (1H) -one), the advantageous preparation of the compound of formula I of the invention is evident.

Následující příklad provedení vynález dokládá, ale nikterak neomezuje.The following exemplary embodiment illustrates the invention but does not limit it in any way.

PříkladExample

4,9-Dihydro-3,9-dimethyl-4-oxo-lH-pyrazolo [ 3,4-b ] chinolin > Z míchané směsi 30 g pyridinu a 44 ml koncentrované kyseliny chlorovodíkové byla postupným zvyšováním teploty na 160 °C oddestilována voda. Při této teplotě bylo přidáno 3,2 g 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo[ 3,4-b] chinolin a směs byla míchána 2 hodiny při teplotě 220 °C. Po ochlazení na 160 °C byla směs nalita do 240 ml vody, směs byla povařena a nerozpustný podíl byl odfiltrován. Látka vyloučená po ochlazení filtrátu byla odsáta a promyta vodou. Krystaly získané krystalizací z ethanolu byly sušeny do konstantní hmotnosti při teplotě 110 °C za tlaku 3 kPa. Bylo získáno 2,32 g látky (77,7 %) o t. t. 248,8 až 249,5 °C.4,9-Dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo [3,4-b] quinoline Water was distilled from a stirred mixture of 30 g of pyridine and 44 ml of concentrated hydrochloric acid by gradually increasing the temperature to 160 ° C. . At this temperature, 3.2 g of 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo [3,4-b] quinoline was added and the mixture was stirred at 220 ° C for 2 hours. After cooling to 160 ° C, the mixture was poured into 240 ml of water, the mixture was boiled and the insoluble matter was filtered off. The precipitate upon cooling of the filtrate was aspirated and washed with water. Crystals obtained by crystallization from ethanol were dried to constant weight at 110 ° C at 3 kPa. 2.32 g (77.7%) of m.p. 248.8-249.5 ° C were obtained.

Claims (1)

Způsob přípravy 4,9-dihydro-3,9-dimethyl-4-oxo-lH-pyrazolo [ 3,4-b ] chinolinu, vyznačující se tím, že se zahřívá 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo [3,4-b ] chinolin s hydrochloridem pyridinu pře teplotě 200 až 240 °C, výhodně při telotě 220 °C.A process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo [3,4-b] quinoline, characterized by heating 4,9-dihydro-2,3,9-trimethyl -4-oxo-2H-pyrazolo [3,4-b] quinoline with pyridine hydrochloride at a temperature of 200 to 240 ° C, preferably at a temperature of 220 ° C.
CS841307A 1983-11-15 1984-02-24 Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline CS235196B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS841307A CS235196B1 (en) 1983-11-15 1984-02-24 Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS838460A CS235183B1 (en) 1983-09-09 1983-11-15 Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline
CS841307A CS235196B1 (en) 1983-11-15 1984-02-24 Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline

Publications (1)

Publication Number Publication Date
CS235196B1 true CS235196B1 (en) 1985-05-15

Family

ID=5435137

Family Applications (2)

Application Number Title Priority Date Filing Date
CS841308A CS235197B1 (en) 1983-11-15 1984-02-24 Process for preparing 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinolines
CS841307A CS235196B1 (en) 1983-11-15 1984-02-24 Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS841308A CS235197B1 (en) 1983-11-15 1984-02-24 Process for preparing 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinolines

Country Status (1)

Country Link
CS (2) CS235197B1 (en)

Also Published As

Publication number Publication date
CS235197B1 (en) 1985-05-15

Similar Documents

Publication Publication Date Title
Robins Potential purine antagonists. I. Synthesis of some 4, 6-substituted pyrazolo [3, 4-d] pyrimidines1
Haworth et al. 157. Synthetic antimalarials. Part XXVII. Some derivatives of phthalazine, quinoxaline, and iso quinoline
SU475768A3 (en) The method of obtaining (5-nitrofuryl-2) -pyridine
DE2113343A1 (en) Indolo- (2,3) - quinolones - prepd by reaction of keto-indoles and anthranilates, followed by dehydration
CS235196B1 (en) Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline
US3361749A (en) Certain n-pyrimidyl anthranilic acid derivatives
CZ299329B6 (en) Process for preparing 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy camptothecin
DE1176660B (en) Process for the preparation of triaryl-substituted imidazolinones-4 (5)
JPH05255328A (en) Glyoxal-n2-acetylguanine adduct and its production
King et al. The Preparation of 2-Substituted Vinyl Quaternary Salts
CS235183B1 (en) Process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline
CN103450132A (en) Synthesis and preparation method of novel sulfanilamide-coumarin derivatives
Petrow et al. 84. New syntheses of heterocyclic compounds. Part II. 2-Phenyl-3: 4: 6: 7-dibenzo-1: 5-naphthyridine
US2673848A (en) 3-alkenylxanthines and their lower 1-alkyl derivatives
US2496364A (en) 3 - sulfanilamido-benzotriazines-1,2,4 and method for their preparation
US2686781A (en) Pyrido (3, 2-d) pyrimidines and process of preparing same
US2442837A (en) Method of preparing heterocyclic organic compounds
US2698846A (en) Heterocyclic compounds
US3155650A (en) 2-substituted-4-sulfanilamidoquinazolines and process
Robson The metabolism of tryptophan: Synthesis of 6-methyl-and 8-methyl-kynurenic acids
US2437853A (en) Preparation of dihydroxanthopterin and xanthopterin
CS268491B1 (en) 7-Chloro-1 (2,4-dinitrophenyl) -6-fluoro-1,4-dihydro-4-oxochonoline-3-carboxylic acid
Baker et al. 6-Methoxy-8-nitroquinolines with Substituents in the 3-and 4-Positions
PL65773B1 (en)
DK141167B (en) Intermediate for use in the preparation of 6,7-dialkoxy-4-hydroxyquinoline esters.